3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
14
Colonic Neoplasms
10
Rectal Neoplasms
9
Pancreatic Neoplasms
8
Cholangiocarcinoma
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Vomiting
5
Stomach Neoplasms
4
Nausea
4
Liver Neoplasms
4
Esophageal Neoplasms
4
Bile Duct Neoplasms
3
Uterine Cervical Neoplasms
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Seminoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pain, Postoperative
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma
1
Malnutrition
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Ringer's Lactate
1
Proctocolectomy, Restorative
1
Photoplethysmography
1
Phlebotomy
1
Lysine Acetyltransferase 5
1
Laparoscopy
1
Infliximab
1
Hydroxyethyl Starch Derivatives
1
Educational Status
1
Dexamethasone
1
Calcium Dobesilate
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Crohn Disease
×
Dexamethasone
×
Gastrointestinal
×
Clear all
NCT05432934
2023-12-07
TAP-DEX
University of Saskatchewan
Phase 1/2
Unknown
60 enrolled